Chemoinformaics analysis of 6,10-Dimethylundeca-5,9-dien-2-ol
| Molecular Weight | 196.334 | nRot | 6 |
| Heavy Atom Molecular Weight | 172.142 | nRig | 2 |
| Exact Molecular Weight | 196.183 | nRing | 0 |
| Solubility: LogS | -3.322 | nHRing | 0 |
| Solubility: LogP | 4.662 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 38.515 |
| nHD | 1 | BPOL | 24.077 |
| QED | 0.64 |
| Synth | 3.105 |
| Natural Product Likeliness | 2.581 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.47 |
| Pgp-sub | 0.027 |
| HIA | 0.007 |
| CACO-2 | -4.391 |
| MDCK | 0.0000173 |
| BBB | 0.421 |
| PPB | 0.941649 |
| VDSS | 2.985 |
| FU | 0.0596094 |
| CYP1A2-inh | 0.771 |
| CYP1A2-sub | 0.298 |
| CYP2c19-inh | 0.272 |
| CYP2c19-sub | 0.677 |
| CYP2c9-inh | 0.155 |
| CYP2c9-sub | 0.918 |
| CYP2d6-inh | 0.019 |
| CYP2d6-sub | 0.163 |
| CYP3a4-inh | 0.049 |
| CYP3a4-sub | 0.198 |
| CL | 14.281 |
| T12 | 0.36 |
| hERG | 0.016 |
| Ames | 0.003 |
| ROA | 0.006 |
| SkinSen | 0.812 |
| Carcinogencity | 0.301 |
| EI | 0.976 |
| Respiratory | 0.015 |
| NR-Aromatase | 0.006 |
| Antiviral | Yes |
| Prediction | 0.590499 |